Literature DB >> 23933165

Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A.

Chaoyun Wang1, Qingxian Huang, Chunhua Wang, Xiaoxi Zhu, Yunfeng Duan, Shuai Yuan, Xianyong Bai.   

Abstract

Inflammation response and oxidative stress play important roles in acute lung injury (ALI). Activation of the cAMP/protein kinase A (PKA) signaling pathway may attenuate ALI by suppressing immune responses and inhibiting the generation of reactive oxygen species (ROS). Hydroxysafflor yellow A (HSYA) is a natural flavonoid compound that reduces oxidative stress and inflammatory cytokine-mediated damage. In this study, we examined whether HSYA could protect the lungs from oleic acid (OA)-induced injury, which was used to mimic ALI, and determined the role of the cAMP/PKA signaling pathway in this process. Arterial oxygen tension (PaO2), carbon dioxide tension, pH, and the PaO2/fraction of inspired oxygen ratio in the blood were detected using a blood gas analyzer. We measured wet/dry lung weight ratio and evaluated tissue morphology. The protein and inflammatory cytokine levels in the bronchoalveolar lavage fluid and serum were determined using enzyme-linked immunoassay. The activities of superoxide dismutase, glutathione peroxidase, PKA, and nicotinamide adenine dinucleotide phosphate oxidase, and the concentrations of cAMP and malondialdehyde in the lung tissue were detected using assay kits. Bcl-2, Bax, caspase 3, and p22(phox) levels in the lung tissue were analyzed using Western blotting. OA increased the inflammatory cytokine and ROS levels and caused lung dysfunction by decreasing cAMP synthesis, inhibiting PKA activity, stimulating caspase 3, and reducing the Bcl-2/Bax ratio. H-89 increased these effects. HSYA significantly increased the activities of antioxidant enzymes, inhibited the inflammatory response via cAMP/PKA pathway activation, and attenuated OA-induced lung injury. Our results show that the cAMP/PKA signaling pathway is required for the protective effect of HSYA against ALI.
© 2013.

Entities:  

Keywords:  Acute lung injury; Hydroxysafflor yellow A; Nicotinamide adenine dinucleotide phosphate oxidase; Protein kinase A; ROS; cAMP

Mesh:

Substances:

Year:  2013        PMID: 23933165     DOI: 10.1016/j.taap.2013.07.021

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

1.  Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Authors:  Shujun Jiang; Zhen Shi; Changyong Li; Chunlei Ma; Xianyong Bai; Chaoyun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 2.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

3.  Chinese Herbal Preparation Xuebijing Potently Inhibits Inflammasome Activation in Hepatocytes and Ameliorates Mouse Liver Ischemia-Reperfusion Injury.

Authors:  Xiqiang Liu; Zhiqiu Hu; Bin Zhou; Xiang Li; Ran Tao
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

4.  Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury.

Authors:  Nianlin Xie; Menglei Huan; Feng Tian; Zhongping Gu; Xiaofei Li
Journal:  Biomed Res Int       Date:  2017-05-15       Impact factor: 3.411

5.  Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.

Authors:  Yanuo Li; Yan Shi; Yan Sun; Luying Liu; Xianyong Bai; Dong Wang; Hongxing Li
Journal:  Mol Med Rep       Date:  2016-11-24       Impact factor: 2.952

6.  Safflor Yellow B Attenuates Ischemic Brain Injury via Downregulation of Long Noncoding AK046177 and Inhibition of MicroRNA-134 Expression in Rats.

Authors:  Chaoyun Wang; Hongzhi Wan; Qiaoyun Wang; Hongliu Sun; Yeying Sun; Kexin Wang; Chunxiang Zhang
Journal:  Oxid Med Cell Longev       Date:  2020-06-03       Impact factor: 6.543

Review 7.  Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury.

Authors:  Xiangyun Li; Nathanial K Berg; Tingting Mills; Kaiying Zhang; Holger K Eltzschig; Xiaoyi Yuan
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

Review 8.  Pharmacological Actions, Molecular Mechanisms, Pharmacokinetic Progressions, and Clinical Applications of Hydroxysafflor Yellow A in Antidiabetic Research.

Authors:  Xilan Zhang; Dayue Shen; Yating Feng; Yuanping Li; Hui Liao
Journal:  J Immunol Res       Date:  2021-12-13       Impact factor: 4.818

Review 9.  Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases.

Authors:  Hui Ao; Wuwen Feng; Cheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-25       Impact factor: 2.629

Review 10.  Herbal Active Ingredients: Potential for the Prevention and Treatment of Acute Lung Injury.

Authors:  Wen-Ying Yu; Chun-Xiao Gao; Huan-Huan Zhang; Yue-Guo Wu; Chen-Huan Yu
Journal:  Biomed Res Int       Date:  2021-06-22       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.